Momenta Pharmaceuticals reports second quarter 2014 financial results
Momenta Pharmaceuticals reported reported a net loss of $(26.2) million, or $(0.51) per share in the 2014 second quarter versus a net loss of $(28.8) million, or $(0.57) per share for the same period in 2013. At June 30, 2014, the company had cash, and equivalents of $202.3 million. July 31, 2014